Tamtam Try Tamtam free
Avantor logo

Avantor account plan

Global provider of products

At a glance

Avantor supplies lab consumables, chemicals and bioprocessing materials to 300,000+ customer locations; FY2025 net sales $6,552.2 million.

Avantor sells products and services to biopharma and healthcare, education and government, and advanced technologies and applied materials customers, through the VWR distribution channel and its own manufactured brands (J.T. Baker, Masterflex, NuSil). It serves more than 300,000 customer locations in approximately 180 countries and had approximately 13,500 employees at December 31, 2025, about 4,800 of them in the U.S. FY2025 net sales were $6,552.2 million (down 3.4%, organic -2.8%), with a net loss of $530.2 million after a $785.0 million goodwill impairment and Adjusted EBITDA of $1,069.4 million (16.3% margin). More than 85% of net sales are recurring. The company has been listed on the NYSE since May 2019 and is led by CEO Emmanuel Ligner since August 2025.

Business units

Strategic priorities

Avantor Revival turnaround
Launched in October 2025 with five pillars: go-to-market and brand architecture, manufacturing and supply chain investment, portfolio scrutiny, net cost savings and simplification, and talent and accountability. The stated goal is a return to growth, which Q3 2026 delivered with organic growth of 5.2%.
Commercial excellence in VWR
Management estimates approximately half of VWR growth in Q3 2026 came from commercial initiatives: large contract renewals, small and mid-sized accounts, and e-commerce after the vwr.com relaunch.
AI and digital sales tools
The VWR Internal Sales Assistant (ISA) combines customer, sales and product data to prepare meetings, generate leads and prioritise opportunities; an AI cross-reference tool suggests substitute products. Approximately 80% of 2025 transactions already came through digital channels.
Pricing to offset inflation
Pricing in 2026 is between 1 and 2%, below inflation; new pricing leaders and tools are in place, and year-end large contracts are the opportunity to raise prices for following years.
Deleveraging
Adjusted net leverage was 3.1x after Q3 2026, with a target below 3x by year end; net debt was reduced by $173 million to $3.235 billion in the quarter.
Long-term framework at Investor Day
An Investor Day on December 8 is to present segments, strategy, capital allocation and a long-term financial framework; 2027 guidance is deferred to the Q4 call in February.

Latest results

In Q3 2026 (quarter ended September 30, 2026) net sales were $1,698.3 million, up 4.6% (organic +5.2%), Avantor's return to year-over-year growth. Net income was $203.4 million against a $711.8 million loss in Q3 2025, which carried the goodwill impairment. Adjusted EBITDA was $256.9 million, a 15.1% margin versus 16.5%, as gross margin fell 90 bps to 31.5% on product mix and inflation. For the nine months, net sales were $4,972.0 million (organic +0.3%) and Adjusted Operating Income fell 12.2% to $643.3 million. 2026 guidance was raised to organic growth of 0.75% to 1.25%, adjusted EPS of $0.81 to $0.83 and free cash flow of $525 million to $550 million.

Investments and deals

Manufacturing and supply chain upgrades
Revival invests in plants, S&OP and on-time delivery in bioprocessing chemicals; a long-term strategy aims to manufacture in Asia, Europe and the US for security of supply. Electronic batch records were introduced at two sites. FY2025 capex was $128.8 million.
E-commerce and leadership hires
vwr.com was relaunched at the end of Q1 / early Q2 2026, a Chief Digital Officer was hired, and a new CIO (Mikey Santiago, from Danaher) and CFO (Todd Garner) completed the executive team; about 65% of N-2 managers were refreshed.
Share buyback
A $500.0 million buyback was authorised in October 2025; $75.0 million was used in November 2025 and $425.0 million remains, with no repurchases in Q3 2026.
Refinancing
In Q4 2025, €400.0 million and €550.0 million term loans replaced earlier term loans and notes, and the revolver was raised to $1,400.0 million. Total debt was $3,946.3 million at December 31, 2025.
Cost transformation and portfolio review
The cost transformation programme targeted approximately $400 million of run-rate gross savings by the end of 2027 and concluded in 2025; Clinical Services was sold in October 2024, and each business is now held to growth, profitability and return targets.

Challenges and risks

Goodwill impairment risk on VWR Distribution
After a $785.0 million impairment in Q3 2025, the unit's fair value exceeded carrying value by only about 5.5% at March 31, 2026, with approximately $2,800.0 million of goodwill allocated to it.
Margin pressure
Q3 2026 Adjusted EBITDA margin fell to 15.1% from 16.5%; VWR adjusted operating margin was 9.7%, hit by mix, inflation and growth investment, and pricing of 1 to 2% trails inflation.
Research funding and Europe
The 10-K names reductions in research budgets and NIH-type government funding as a key risk; academic and government sales fell double digits in Q3 2025, and Europe is lagging on energy costs and government funding pressure.
Competition and plant reliability
Avantor operates in a fragmented, highly competitive market and lost some large lab services accounts; in 2025, plant downtime, raw material availability and equipment uptime limited bioprocessing chemical shipments.
Indebtedness and tariffs
Gross principal of $3,967.9 million, tariffs and trade policy, and FX exposure to the Euro are listed among the key risks.

What leadership says

“We estimate that approximately half of VWR growth in Q3 was driven by our commercial initiatives”

Emmanuel Ligner, President and Chief Executive Officer · Avantor Q3 2026 earnings call, 2026-10-28

“our number one objective is pricing to offset inflation right now”

Emmanuel Ligner, President and Chief Executive Officer · Avantor Q3 2026 earnings call, 2026-10-28

“we are going to scrutinize whether we are the right owner for them”

Emmanuel Ligner, President and Chief Executive Officer · Avantor Q3 2025 earnings call (Avantor Revival launch), 2025-10-29

“accountability will be my North Star.”

Emmanuel Ligner, President and Chief Executive Officer · Avantor Q3 2025 earnings call (Avantor Revival launch), 2025-10-29

Where a supplier can help

Sales productivity and AI tooling for VWR
Tied to the commercial excellence priority and the VWR Internal Sales Assistant: suppliers of sales data, lead generation and account-prioritisation tools can help extend the commercial initiatives that drove about half of VWR growth.
E-commerce and digital channel
Tied to the vwr.com relaunch and the new Chief Digital Officer: platform, search, recommendation and content providers fit a channel that already carries most transactions.
Plant reliability and supply chain
Tied to the manufacturing and supply chain investment pillar and the 2025 shipment limits in bioprocessing chemicals: maintenance, equipment uptime, S&OP and multi-region sourcing offers address a stated constraint.
Pricing and margin tools
Tied to the margin pressure challenge and the pricing priority: pricing analytics and cost-to-serve tools help a business whose pricing trails inflation.

Tamtam's reading of the priorities and challenges above, not the company's own words.

Selling to companies like Avantor?

Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.

Find similar companies

Key documents

Read in full by Tamtam; each summary links to the document itself.

Questions about Avantor

What does Avantor do?

Avantor supplies lab consumables, chemicals, equipment and services through its VWR channel, and manufactures bioprocessing materials, high-purity chemicals and NuSil silicones for biopharma, healthcare, education and advanced technology customers.

What is Avantor's revenue?

FY2025 net sales were $6,552.2 million, down 3.4%. Q3 2026 net sales were $1,698.3 million, up 4.6%.

How many employees does Avantor have?

Approximately 13,500 at December 31, 2025, about 4,800 of them in the U.S.

Who leads Avantor?

Emmanuel Ligner has been President and CEO since August 2025; Mary Blenn is COO and Todd Garner joined as CFO in September 2026.

What is Avantor's strategy?

The Avantor Revival programme focuses on go-to-market and brands, manufacturing and supply chain, portfolio scrutiny, cost simplification and talent, with the goal of returning to profitable growth.

Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-17)